Abstract:Preimplantation tissue typing has been proposed as a method for creating a tissue matched child that can serve as a haematopoietic stem cell donor to save its sick sibling in need of a stem cell transplant. Despite recent promising results, many people have expressed their disapproval of this method. This paper addresses the main concerns of these critics: the risk of preimplantation genetic diagnosis (PGD) for the child to be born; the intention to have a donor child; the limits that should be placed on what … Show more
“…In conclusion, despite ethical issues involved in preimplantation HLA typing [28][29][30][31], the presented results show the increasing attractiveness of this option for the couples with affected children requiring HLA compatible stem cell transplantation. So, the couples at risk of having children with congenital bone marrow disorders have to be informed about presently available option not only for avoiding the birth of affected child, but also for selecting a suitable stem cell donor for their affected siblings, which may presently be a realistic hope for treating of siblings with congenital bone marrow failures.…”
Since we have first introduced preimplantation HLA typing more than 16 years ago, it has become a practical option for stem cell transplantation treatment of congenital and acquired bone marrow failures. This paper summarises our experience of 390 preimplantation HLA typing, representing a part of preimplantation genetic diagnosis (PGD) series, which is the world's largest PGD experience, involving PGD for approximately 500 genetic conditions. The proportion of PGD cases performed combined with HLA typing is steadily increasing, with iimproved awareness of at risk couples regarding PGD as a realistic option for radical treatment of their affected children with bone marrow failures. Preimplantation HLA typing involves detection and transfer of HLA matched unaffecetd embryos, to obtain an HLA compatible offspring as potential donors for their affected siblings. Available results of HLA matched stem cell transplantation treatment following PGD shows a successful hematopoietic reconstitution of patients with different conditions, suggesting that PGD is an efficient approach for HLA matched stem cell transplantation treatment of congetital and acquired bone marrow failures.
“…In conclusion, despite ethical issues involved in preimplantation HLA typing [28][29][30][31], the presented results show the increasing attractiveness of this option for the couples with affected children requiring HLA compatible stem cell transplantation. So, the couples at risk of having children with congenital bone marrow disorders have to be informed about presently available option not only for avoiding the birth of affected child, but also for selecting a suitable stem cell donor for their affected siblings, which may presently be a realistic hope for treating of siblings with congenital bone marrow failures.…”
Since we have first introduced preimplantation HLA typing more than 16 years ago, it has become a practical option for stem cell transplantation treatment of congenital and acquired bone marrow failures. This paper summarises our experience of 390 preimplantation HLA typing, representing a part of preimplantation genetic diagnosis (PGD) series, which is the world's largest PGD experience, involving PGD for approximately 500 genetic conditions. The proportion of PGD cases performed combined with HLA typing is steadily increasing, with iimproved awareness of at risk couples regarding PGD as a realistic option for radical treatment of their affected children with bone marrow failures. Preimplantation HLA typing involves detection and transfer of HLA matched unaffecetd embryos, to obtain an HLA compatible offspring as potential donors for their affected siblings. Available results of HLA matched stem cell transplantation treatment following PGD shows a successful hematopoietic reconstitution of patients with different conditions, suggesting that PGD is an efficient approach for HLA matched stem cell transplantation treatment of congetital and acquired bone marrow failures.
“…PGD to immunologically match a sibling to a sick child [4][5]11 Selecting an embryo with a human leukocyte antigen-type match to save the life of a sick older sibling.…”
“…This particular risk level must then be compared to the perceived benefits of PGD/HLA tissue typing, as it should only be permissible if the child to be born "is likely to derive enough benefit to outweigh these risks" [8]. This ratio may very well tilt in favor of PGD with HLA typing but not Preimplantation HLA tissue typing.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.